South Korea’s MFDS gave regulatory clearance to SK Inc. C&C’s artificial intelligence (AI) solution to diagnose cerebral infarction called Medical Insight+ Brain Infarct on Feb. 22, as a class III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback